Talphera (FRA:R5XA) Cyclically Adjusted PB Ratio: (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:R5XA Talphera Inc FRA:R5XA
35 GF Score
Price €1.00
! 4 Warning Signs
View Full Analysis

What is Talphera Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Talphera  (FRA:R5XA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Talphera Cyclically Adjusted PB Ratio Related Terms


Talphera Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Talphera's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talphera Cyclically Adjusted PB Ratio Chart

Talphera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.34 0.89 2.32 0.00 0.00

Talphera Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:R5XA vs CPHI, ZYBT, INCR: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Talphera's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Talphera Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Talphera's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Talphera's Cyclically Adjusted PB Ratio falls into.


FRA:R5XA
35GF Score
Talphera Inc FRA:R5XA
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Talphera Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Talphera's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Talphera's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.241/333.9520*333.9520
=0.241

Current CPI (Jun. 2026) = 333.9520.

Talphera Quarterly Data

Book Value per Share CPI Adj_Book
201609 1.286 241.428 1.779
201612 -2.232 241.432 -3.087
201703 -8.100 243.801 -11.095
201706 -12.404 244.955 -16.911
201709 -10.245 246.819 -13.862
201712 -12.122 246.524 -16.421
201803 -14.910 249.554 -19.952
201806 -15.722 251.989 -20.836
201809 -10.480 252.439 -13.864
201812 0.949 251.233 1.261
201903 -1.771 254.202 -2.327
201906 -4.131 256.143 -5.386
201909 -6.452 256.759 -8.392
201912 -9.368 256.974 -12.174
202003 -12.442 258.115 -16.098
202006 -13.201 257.797 -17.101
202009 -10.857 260.280 -13.930
202012 -9.275 260.474 -11.891
202103 -3.853 264.877 -4.858
202106 -5.013 271.696 -6.162
202109 -6.129 274.310 -7.462
202112 -4.643 278.802 -5.561
202203 -4.725 287.504 -5.488
202206 4.256 296.311 4.797
202209 3.713 296.808 4.178
202212 2.498 296.797 2.811
202303 1.218 301.836 1.348
202306 0.875 305.109 0.958
202309 1.012 307.789 1.098
202312 0.763 306.746 0.831
202403 0.884 312.332 0.945
202406 0.696 314.175 0.740
202409 0.510 315.301 0.540
202412 0.449 315.605 0.475
202503 0.303 319.799 0.316
202506 0.280 322.561 0.290
202509 0.358 324.800 0.368
202512 0.295 324.054 0.304
202603 0.319 330.213 0.323
202606 0.241 333.952 0.241

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Talphera Business Description

Other Exchanges TLPH:USA
Address 1850 Gateway Drive, Suite 175, San Mateo, CA, USA, 94404
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
35GF Score

Get the complete analysis for FRA:R5XA

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00
Price